Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1347531
PUBLISHER: IMARC | PRODUCT CODE: 1347531
Ulcerative Colitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 146 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Market Overview:
The global ulcerative colitis market size reached US$ 7.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.
Ulcerative colitis (UC) refers to a chronic inflammatory bowel disease (IBD) that causes irritation, inflammation, and ulcers (sores) in the digestive tract. It typically affects the inner lining of the large intestine (or colon) and rectum. The symptoms generally develop over time, and individuals diagnosed with UC may experience periods of mild or no symptoms. However, it can sometimes lead to debilitating or life-threatening complications. While there is no cure for UC yet, the treatment can help patients manage and reduce their symptoms, prevent flare-ups, and bring about long-term remission. As a result, UC treatment is rapidly gaining traction across the globe as it can help enhance the quality of life and ensure the physical and mental wellbeing of the patients.
Ulcerative Colitis Market Trends:
The widespread prevalence of UC disease and the rising awareness regarding the available treatment options represent the primary factors driving the market growth. Besides this, the presence of strong pipeline products and continuous advancements in numerous drugs are augmenting the product demand. Additionally, governments of various countries are taking several initiatives to spread awareness about the condition and enhance the accessibility and availability of proper healthcare facilities. This, in confluence with the increasing investments in the research and development (R&D) activities for the development of novel therapies, is propelling the market growth. Furthermore, the leading players are focusing on launching innovative and more effective drugs to expand their product portfolio and gain a competitive edge in the market. Other factors, including the easy availability of biosimilar drugs, improving healthcare infrastructure, favorable reimbursement policies, and increasing consumer spending on healthcare, are also creating a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global ulcerative colitis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, disease type, molecule type, drug type, route of administration and distribution channel.
Breakup by Type:
Mild UC
Moderate UC
Severe UC
Breakup by Disease Type:
Ulcerative Proctitis
Proctosigmoiditis
Left-sided Colitis
Pancolitis or Universal Colitis
Fulminant Colitis
Breakup by Molecule Type:
Small Molecules
Biologics
Breakup by Drug Type:
Anti-Inflammatory Drugs
Anti-TNF Biologics
Immunosuppressant
Calcineurin Inhibitors
Others
Breakup by Route of Administration:
Oral
Injectable
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Drug Store
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
- How has the global ulcerative colitis market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global ulcerative colitis market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the disease type?
- What is the breakup of the market based on the molecule type?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the route of administration?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global ulcerative colitis market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112023A5663
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Ulcerative Colitis Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Mild UC
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Moderate UC
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Severe UC
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Disease Type
- 7.1 Ulcerative Proctitis
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Proctosigmoiditis
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Left-sided Colitis
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Pancolitis or Universal Colitis
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Fulminant Colitis
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Molecule Type
- 8.1 Small Molecules
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Biologics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Drug Type
- 9.1 Anti-Inflammatory Drugs
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Anti-TNF Biologics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Immunosuppressant
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Calcineurin Inhibitors
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Market Breakup by Route of Administration
- 10.1 Oral
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Injectable
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
11 Market Breakup by Distribution Channel
- 11.1 Hospital Pharmacies
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
- 11.2 Retail Pharmacies
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
- 11.3 Drug Store
- 11.3.1 Market Trends
- 11.3.2 Market Forecast
- 11.4 Others
- 11.4.1 Market Trends
- 11.4.2 Market Forecast
12 Market Breakup by Region
- 12.1 North America
- 12.1.1 United States
- 12.1.1.1 Market Trends
- 12.1.1.2 Market Forecast
- 12.1.2 Canada
- 12.1.2.1 Market Trends
- 12.1.2.2 Market Forecast
- 12.1.1 United States
- 12.2 Asia-Pacific
- 12.2.1 China
- 12.2.1.1 Market Trends
- 12.2.1.2 Market Forecast
- 12.2.2 Japan
- 12.2.2.1 Market Trends
- 12.2.2.2 Market Forecast
- 12.2.3 India
- 12.2.3.1 Market Trends
- 12.2.3.2 Market Forecast
- 12.2.4 South Korea
- 12.2.4.1 Market Trends
- 12.2.4.2 Market Forecast
- 12.2.5 Australia
- 12.2.5.1 Market Trends
- 12.2.5.2 Market Forecast
- 12.2.6 Indonesia
- 12.2.6.1 Market Trends
- 12.2.6.2 Market Forecast
- 12.2.7 Others
- 12.2.7.1 Market Trends
- 12.2.7.2 Market Forecast
- 12.2.1 China
- 12.3 Europe
- 12.3.1 Germany
- 12.3.1.1 Market Trends
- 12.3.1.2 Market Forecast
- 12.3.2 France
- 12.3.2.1 Market Trends
- 12.3.2.2 Market Forecast
- 12.3.3 United Kingdom
- 12.3.3.1 Market Trends
- 12.3.3.2 Market Forecast
- 12.3.4 Italy
- 12.3.4.1 Market Trends
- 12.3.4.2 Market Forecast
- 12.3.5 Spain
- 12.3.5.1 Market Trends
- 12.3.5.2 Market Forecast
- 12.3.6 Russia
- 12.3.6.1 Market Trends
- 12.3.6.2 Market Forecast
- 12.3.7 Others
- 12.3.7.1 Market Trends
- 12.3.7.2 Market Forecast
- 12.3.1 Germany
- 12.4 Latin America
- 12.4.1 Brazil
- 12.4.1.1 Market Trends
- 12.4.1.2 Market Forecast
- 12.4.2 Mexico
- 12.4.2.1 Market Trends
- 12.4.2.2 Market Forecast
- 12.4.3 Others
- 12.4.3.1 Market Trends
- 12.4.3.2 Market Forecast
- 12.4.1 Brazil
- 12.5 Middle East and Africa
- 12.5.1 Market Trends
- 12.5.2 Market Breakup by Country
- 12.5.3 Market Forecast
13 SWOT Analysis
- 13.1 Overview
- 13.2 Strengths
- 13.3 Weaknesses
- 13.4 Opportunities
- 13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
- 15.1 Overview
- 15.2 Bargaining Power of Buyers
- 15.3 Bargaining Power of Suppliers
- 15.4 Degree of Competition
- 15.5 Threat of New Entrants
- 15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
- 17.1 Market Structure
- 17.2 Key Players
- 17.3 Profiles of Key Players
- 17.3.1 Abbott Laboratories
- 17.3.1.1 Company Overview
- 17.3.1.2 Product Portfolio
- 17.3.1.3 Financials
- 17.3.1.4 SWOT Analysis
- 17.3.2 AbbVie Inc.
- 17.3.2.1 Company Overview
- 17.3.2.2 Product Portfolio
- 17.3.2.3 Financials
- 17.3.2.4 SWOT Analysis
- 17.3.3 AstraZeneca plc
- 17.3.3.1 Company Overview
- 17.3.3.2 Product Portfolio
- 17.3.3.3 Financials
- 17.3.3.4 SWOT Analysis
- 17.3.4 Bristol-Myers Squibb Company
- 17.3.4.1 Company Overview
- 17.3.4.2 Product Portfolio
- 17.3.4.3 Financials
- 17.3.4.4 SWOT Analysis
- 17.3.5 Eli Lilly and Company
- 17.3.5.1 Company Overview
- 17.3.5.2 Product Portfolio
- 17.3.5.3 Financials
- 17.3.5.4 SWOT Analysis
- 17.3.6 F. Hoffmann-La Roche Ltd.
- 17.3.6.1 Company Overview
- 17.3.6.2 Product Portfolio
- 17.3.6.3 Financials
- 17.3.7 GlaxoSmithKline plc
- 17.3.7.1 Company Overview
- 17.3.7.2 Product Portfolio
- 17.3.7.3 Financials
- 17.3.7.4 SWOT Analysis
- 17.3.8 Johnson & Johnson
- 17.3.8.1 Company Overview
- 17.3.8.2 Product Portfolio
- 17.3.8.3 Financials
- 17.3.8.4 SWOT Analysis
- 17.3.9 Merck & Co. Inc.
- 17.3.9.1 Company Overview
- 17.3.9.2 Product Portfolio
- 17.3.9.3 Financials
- 17.3.9.4 SWOT Analysis
- 17.3.10 Pfizer Inc.
- 17.3.10.1 Company Overview
- 17.3.10.2 Product Portfolio
- 17.3.10.3 Financials
- 17.3.10.4 SWOT Analysis
- 17.3.11 Takeda Pharmaceutical Company Limited
- 17.3.11.1 Company Overview
- 17.3.11.2 Product Portfolio
- 17.3.11.3 Financials
- 17.3.11.4 SWOT Analysis
- 17.3.12 Teva Pharmaceutical Industries Ltd.
- 17.3.12.1 Company Overview
- 17.3.12.2 Product Portfolio
- 17.3.12.3 Financials
- 17.3.12.4 SWOT Analysis
- 17.3.1 Abbott Laboratories
Product Code: SR112023A5663
List of Figures
- Figure 1: Global: Ulcerative Colitis Market: Major Drivers and Challenges
- Figure 2: Global: Ulcerative Colitis Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Ulcerative Colitis Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Ulcerative Colitis Market: Breakup by Type (in %), 2022
- Figure 5: Global: Ulcerative Colitis Market: Breakup by Disease Type (in %), 2022
- Figure 6: Global: Ulcerative Colitis Market: Breakup by Molecule Type (in %), 2022
- Figure 7: Global: Ulcerative Colitis Market: Breakup by Drug Type (in %), 2022
- Figure 8: Global: Ulcerative Colitis Market: Breakup by Route of Administration (in %), 2022
- Figure 9: Global: Ulcerative Colitis Market: Breakup by Distribution Channel (in %), 2022
- Figure 10: Global: Ulcerative Colitis Market: Breakup by Region (in %), 2022
- Figure 11: Global: Ulcerative Colitis (Mild UC) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Ulcerative Colitis (Mild UC) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Ulcerative Colitis (Moderate UC) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Ulcerative Colitis (Moderate UC) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Ulcerative Colitis (Severe UC) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Ulcerative Colitis (Severe UC) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Ulcerative Colitis (Ulcerative Proctitis) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Ulcerative Colitis (Ulcerative Proctitis) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Ulcerative Colitis (Proctosigmoiditis) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Ulcerative Colitis (Proctosigmoiditis) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Ulcerative Colitis (Left-sided Colitis) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Ulcerative Colitis (Left-sided Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Ulcerative Colitis (Pancolitis or Universal Colitis) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Ulcerative Colitis (Pancolitis or Universal Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Ulcerative Colitis (Fulminant Colitis) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Ulcerative Colitis (Fulminant Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Ulcerative Colitis (Small Molecules) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Ulcerative Colitis (Small Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Global: Ulcerative Colitis (Biologics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Global: Ulcerative Colitis (Biologics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: Global: Ulcerative Colitis (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: Global: Ulcerative Colitis (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: Global: Ulcerative Colitis (Anti-TNF Biologics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: Global: Ulcerative Colitis (Anti-TNF Biologics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Global: Ulcerative Colitis (Immunosuppressant) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Global: Ulcerative Colitis (Immunosuppressant) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: Global: Ulcerative Colitis (Calcineurin Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: Global: Ulcerative Colitis (Calcineurin Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: Global: Ulcerative Colitis (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: Global: Ulcerative Colitis (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: Global: Ulcerative Colitis (Oral) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: Global: Ulcerative Colitis (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: Global: Ulcerative Colitis (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: Global: Ulcerative Colitis (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: Global: Ulcerative Colitis (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: Global: Ulcerative Colitis (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: Global: Ulcerative Colitis (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: Global: Ulcerative Colitis (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Global: Ulcerative Colitis (Drug Store) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Global: Ulcerative Colitis (Drug Store) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: Global: Ulcerative Colitis (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: Global: Ulcerative Colitis (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: North America: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: North America: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: United States: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: United States: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: Canada: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: Canada: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: Asia-Pacific: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: Asia-Pacific: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: China: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: China: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Japan: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Japan: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: India: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: India: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: South Korea: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: South Korea: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Australia: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Australia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Indonesia: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Indonesia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Europe: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Europe: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Germany: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 78: Germany: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 79: France: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 80: France: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 81: United Kingdom: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 82: United Kingdom: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 83: Italy: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 84: Italy: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 85: Spain: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 86: Spain: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 87: Russia: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 88: Russia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 89: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 90: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 91: Latin America: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 92: Latin America: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 93: Brazil: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 94: Brazil: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 95: Mexico: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 96: Mexico: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 97: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 98: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 99: Middle East and Africa: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
- Figure 100: Middle East and Africa: Ulcerative Colitis Market: Breakup by Country (in %), 2022
- Figure 101: Middle East and Africa: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 102: Global: Ulcerative Colitis Industry: SWOT Analysis
- Figure 103: Global: Ulcerative Colitis Industry: Value Chain Analysis
- Figure 104: Global: Ulcerative Colitis Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Ulcerative Colitis Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Ulcerative Colitis Market Forecast: Breakup by Type (in Million US$), 2023-2028
- Table 3: Global: Ulcerative Colitis Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
- Table 4: Global: Ulcerative Colitis Market Forecast: Breakup by Molecule Type (in Million US$), 2023-2028
- Table 5: Global: Ulcerative Colitis Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
- Table 6: Global: Ulcerative Colitis Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
- Table 7: Global: Ulcerative Colitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
- Table 8: Global: Ulcerative Colitis Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 9: Global: Ulcerative Colitis Market: Competitive Structure
- Table 10: Global: Ulcerative Colitis Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.